153 related articles for article (PubMed ID: 37652523)
1. Clinical Outcomes of Radiotherapy for Stage 1 Glottic Carcinoma: Comparing Accelerated Hyperfractionation and Once-daily Fractionation.
Endo M; Fukuda Y; Okada K; Ogawa K; Nakamura M; Takahashi S; Murakami E; Shibayama C; Kawahara M; Akahane K; Onaga R; Nagatomo T; Kanazawa T; Nishino H; Mori H; Shirai K
In Vivo; 2023; 37(5):2320-2326. PubMed ID: 37652523
[TBL] [Abstract][Full Text] [Related]
2. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation.
Awwad HK; Lotayef M; Shouman T; Begg AC; Wilson G; Bentzen SM; Abd El-Moneim H; Eissa S
Br J Cancer; 2002 Feb; 86(4):517-23. PubMed ID: 11870530
[TBL] [Abstract][Full Text] [Related]
3. Esophageal cancer treated with radiotherapy: impact of total treatment time and fractionation.
Nishimura Y; Ono K; Tsutsui K; Oya N; Okajima K; Hiraoka M; Abe M
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1099-105. PubMed ID: 7961017
[TBL] [Abstract][Full Text] [Related]
4. Advantage of accelerated fractionation regimens in definitive radiotherapy for stage II glottic carcinoma.
Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
Ann Otol Rhinol Laryngol; 2006 Oct; 115(10):727-32. PubMed ID: 17076093
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Three Fractionation Schedules in Radiotherapy for Early Glottic Squamous Cell Carcinoma.
Suzuki G; Yamazaki H; Aibe N; Masui K; Shimizu D; Kimoto T; Nishimura T; Kawabata K; Nagasawa S; Machida K; Yoshino Y; Watanabe S; Sugiyama Y; Arai A; Hirano S; Yamada K
In Vivo; 2020; 34(5):2769-2774. PubMed ID: 32871813
[TBL] [Abstract][Full Text] [Related]
6. Accelerated radiotherapy for T1 to T2 glottic cancer.
Motegi A; Kawashima M; Arahira S; Zenda S; Toshima M; Onozawa M; Hayashi R; Akimoto T
Head Neck; 2015 Apr; 37(4):579-84. PubMed ID: 24677592
[TBL] [Abstract][Full Text] [Related]
7. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation.
Awwad HK; Khafagy Y; Barsoum M; Ezzat S; el-Attar I; Farag H; Akoush H; Meabid H; Zaghloul MS
Radiother Oncol; 1992 Dec; 25(4):261-6. PubMed ID: 1480771
[TBL] [Abstract][Full Text] [Related]
8. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
Krstevska V; Crvenkova S
Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
[TBL] [Abstract][Full Text] [Related]
9. Hyperfractionation as an altered fractionation regimen in primary radiotherapy for squamous cell carcinoma of the larynx.
Krstevska V; Smichkoska S
Prilozi; 2006 Dec; 27(2):175-87. PubMed ID: 17211301
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy plus conventional radiotherapy or accelerated hyperfractionation in stage III and IV nasopharyngeal carcinoma--a phase II study.
El-Weshi A; Khafaga Y; Allam A; Mosseri V; Ibrahim E; El-Serafi M; El-Badawi S
Acta Oncol; 2001; 40(5):574-81. PubMed ID: 11669328
[TBL] [Abstract][Full Text] [Related]
11. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
12. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
[TBL] [Abstract][Full Text] [Related]
13. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study.
Moon SH; Cho KH; Chung EJ; Lee CG; Lee KC; Chai GY; Kang KM; Lee JY; Chung WK; Park WY; Kim JH
Radiother Oncol; 2014 Jan; 110(1):98-103. PubMed ID: 24161568
[TBL] [Abstract][Full Text] [Related]
14. Altered-fractionation radiotherapy improves local control in early-stage glottic carcinoma: A systematic review and meta-analysis of 1762 patients.
Sapienza LG; Ning MS; Taguchi S; Calsavara VF; Pellizzon ACA; Gomes MJL; Kowalski LP; Baiocchi G
Oral Oncol; 2019 Jun; 93():8-14. PubMed ID: 31109700
[TBL] [Abstract][Full Text] [Related]
15. Results of radiation therapy for hypopharyngeal carcinoma: impact of accelerated hyperfractionation on prognosis.
Akimoto T; Mitsuhashi N; Sakurai H; Takahashi T; Yamakawa M; Hayakawa K; Kiryu Y; Niibe H
Jpn J Clin Oncol; 1996 Jun; 26(3):169-74. PubMed ID: 8656559
[TBL] [Abstract][Full Text] [Related]
16. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
[TBL] [Abstract][Full Text] [Related]
17. The role of postradiotherapy neck dissection in supraglottic carcinoma.
Chan AW; Ancukiewicz M; Carballo N; Montgomery W; Wang CC
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):367-75. PubMed ID: 11380223
[TBL] [Abstract][Full Text] [Related]
18. Definitive radiation therapy for moderately advanced laryngeal cancer: effects of accelerated hyperfractionation.
Okubo M; Nishimura Y; Shibata T; Nakamatsu K; Kanamori S; Tachibana I; Koike R; Nishikawa T; Mori K
Jpn J Clin Oncol; 2010 Oct; 40(10):944-8. PubMed ID: 20534687
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512).
Trotti A; Zhang Q; Bentzen SM; Emami B; Hammond ME; Jones CU; Morrison WH; Sagar SM; Ridge JA; Fu KK; Ang KK
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):958-963. PubMed ID: 25035199
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control.
Nishimura Y; Nagata Y; Okajima K; Mitsumori M; Hiraoka M; Masunaga S; Ono K; Shoji K; Kojima H
Radiother Oncol; 1996 Sep; 40(3):225-32. PubMed ID: 8940749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
